NVCR stock news
This page provides real-time market news, earnings updates, and company announcements related to NovoCure Limited (NVCR).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-13 16:05 EST
The U.S. Food and Drug Administration (FDA) has officially approved NovoCure Limited's tumor treatment device, Optune Pax, for the treatment of locally advanced pancreatic cancer.
老虎证券2026-02-11 22:51:56
NovoCure (NVCR) Stock Is Trending Overnight - Here's What You Should Know
Finviz2026-02-12 02:57:39
NVCR stock chart
NVCR stock detailsNVCR stock price change
On the last trading day, NVCR stock closed at 14.40 USD, with a price change of 37.14% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more